Japanese

 

 

 

   Last Modified

   15 November 2017

Theoretical Organic Chemistry Nuclear Receptor Chemistry Structural Bioinformatics Rational Drug Design

Homology Modeling for HyperChem Logo Gaussian Interface for HyperChem Logo Full-Auto Interactive, Muti-layer ONIOM Interface Logo Docking Study with HyperChem Logo Mol Dimension Logo Virtual Screening System Technology The Next-generation Drug Design Technology Drug Design Methodology for Organic Chemists HyperChem

 

Announce

What's New in Revision G1.

2017/04/10 Compatible to Gaussian16

2016/03/26 The function of ONIOM Interface is strengthened and available for calculating the whole system.

 


Docking Study with HyperChem, Revision G1

- Carrying The Next-generation Drug Discovery Technology, The PIEFII Technology -

 

Powered by Docking Study with HyperChem   THE IMPOSSIBLE BECOMES POSSIBLE.

Advanced Technology & The High-Performance, Biomacromolecule- & Ligand-Flexible Docking & Screening Program Package

Docking Study with HyperChem supports the comprehensive and automatic biomacromolecule (protein and nucleic acid molecule systems)- and ligand (small molecule and peptide)-flexible docking simulations, and thus supports the drug design and the in silico screening of a drug candidate.

Docking Study with HyperChem can reproduce the crystal structure at the most stable docking mode but not other docking programs.


Homology Modeling Professional for HyperChem, Revision G1

with Gaussian Interface for HyperChem & ONIOM Interface for Receptor

 

Powered by Homology Modeling for HyperChem   THE IMPOSSIBLE BECOMES POSSIBLE.

New, High-Performance Software for Protein Modeling, Functional Analysis, and Simulation.

Homology Modeling for HyperChem is the latest molecular modeling package which can carry out the molecular modeling, functional analysis, and simulations of a big molecular system using comprehensively the ab-initio quantum chemistry calculations and the molecular dynamics simulations as well as the molecular mechanics calculations. The program can control seamlessly both HyperChem and Gaussian packages and can be simultaneously fed back their calculation results to the big molecular system in the HyperChem graphical user interface. The whole molecular system can be operated in a quantum chemistry via the full-automatic ONIOM interface to Gaussian. All operations are fully automated in the GUI-based manner, and thus the program supports the logical molecular modeling, functional analysis, and simulations in the life science research such as the structure-based drug design, as well as an unexplored research.

Homology Modeling Professional for HyperChem strongly supports the latest in-silico technique.


 


                  The Next-generation Drug Discovery Technology

                                        PEIFII

                                     Ab-Initio Biomacromolecule-Ligand Interaction Site

                        Structure-based Pharmacophore Prediction Technology

                                      Potential Ligand Prediction Technology

                                          A New Drug Design Methodology


 

 

Latest News   Archives


2018/03/25-28   Motonori Tsuji will speak a research entitled "Antagonist-Perturbation Mechanism for Activation Function-2 Fixed Motifs: Active Conformation and Docking Mode of Retinoid X Receptor Antagonists" at the 138th annual meeting of the pharmaceutical society of Japan.

2017/11/19   Motonori Tsuji spoke a research entitled "Identifying the Receptor Subtype Selectivity of Retinoids via Docking, QM/MM, and Quantum Mechanics Calculations: ATRA Can Act as an Endogenous RXR Ligand" at the 28th symposium of retinoids of Japan society for retinoid research.

2017/05/16   Origin of the agonism and antagonism mechanisms in the nuclear receptors via quantum mechanics (using core technologies of Docking Study with HyperChem and Homology Modeling Professional for HyperChem) has been accepted for publication. Motonori Tsuji. J. Comput. Aided Mol. Des. 31, 577-585, 2017, DOI: 10.1007/s10822-017-0025-6.

2017/04/16   Confirmed that the products are compatible to Gaussian16W 64-bit multi-processor version (Revision A.03). I really appreciate great help of Gaussian, Inc.

2017/03/28   All series of HyperChem of Hypercube, Inc. are available from our web site.

2017/03/27   Motonori Tsuji spoke a research entitled "Helix H3 Three-Point Initial-Binding Hypothesis: Understanding of Both the Ligand-Trapping Mechanism and the Simultaneous Structural Transition from Apo-Form to Holo-Form of the Ligand-Binding Domain in the Nuclear Receptor Superfamily" at the 137th annual meeting of the pharmaceutical society of Japan.

2017/02/15   Press Release: Origin of the receptor subtype selectivity via quantum mechanics has been published. Motonori Tsuji, et. al. FEBS Open Bio. 7, 391-396, 2017, DOI: 10.1002/2211-5463.12188.

2016/12/29   Origin of the receptor subtype selectivity via quantum mechanics has been accepted for publication.

2016/04/16   Confirmed that ONIOM Interface for Receptor and Gaussian Interface for HyperChem were compatible with the latest Gaussian09W (64bit-multiprocessor version, Revision E.01) under support of Gaussian, Inc. I really appreciate great help of Gaussian, Inc.

2016/03/27   Motonori Tsuji spoke a research entitled "Geometrical Dependence of the Highest Occupied Molecular Orbital in Bicyclic Systems: Origin of the Facial Stereoselectivity of Bicyclic Olefins" at the 136th annual meeting of the pharmaceutical society of Japan.

2016/03/26   Announcing  Docking Study with HyperChem 2016 and Homology Modeling Professional for HyperChem 2016, Revision G1.

2016/03/26   The function of ONIOM Interface for Receptor was strengthened (compatible to whole system of protein and nucleic acid molecular system).

2015/12/01   Confirmed that Docking Study with HyperChem and Homology Modeling Professional for HyperChem were compatible with Windows 10 Professional (64 bit Version).

2015/11/04   Press Release: Origin of the ligand recognition mechanism in the nuclear receptor superfamily has been published. Motonori Tsuji. J. Mol. Graph. Model. 62, 262-275, 2015.

2015/10/07   The first success of the structural transition of the holo-form formation simulations and the discovery of the driving forces involved in the ligand entry in the nuclear receptor superfamily using Docking Study with HyperChem and Homology Modeling Professional for HyperChem has been accepted for publication.

2015/09/13   A proposed molecular mechanism of ATRA via retinoid X receptors (using core technologies of Docking Study with HyperChem and Homology Modeling Professional for HyperChem) has been accepted for publication. Motonori Tsuji, et. al. J. Comput. Aided Mol. Des. 29, 975-988, 2015.

2015/04/17   Press Release: Origin of the facial stereoselectivity, which is the most important and unsolved issue in organic chemistry, has recently been accepted for publication. Motonori Tsuji. Asian J. Org. Chem. 4, 659-673, 2015.

2015/03/26   Motonori Tsuji spoke a research entitled "Structure and function of the local motifs in the canonical structure of the ligand-binding domain in the nuclear receptor superfamily" at the 135th annual meeting of the pharmaceutical society of Japan.

2015/01/04   Announcing  Docking Study with HyperChem 2015 and Homology Modeling Professional for HyperChem 2015, Revision G1.

2014/10/14   Announcing  Docking Study with HyperChem and Homology Modeling Professional for HyperChem, Revision F3.

2014/10/02   Confirmed that Docking Study with HyperChem and Homology Modeling Professional for HyperChem were compatible with Windows 10 Technical Preview (64 bit Version).

2014/03/18   A paper regarding the folding mechanism and the agonism and atagonism mechanism of the ligand-binding domain in the nuclear receptor superfamily has recently been published. Motonori Tsuji J. Struct. Biol. 185, 355-365, 2014.


 

Topics


2017/05/16   Origin of the agonism and antagonism mechanisms in the nuclear receptors via quantum mechanics has been accepted for publication. Motonori Tsuji. J. Comput. Aided Mol. Des. 31, 577-585, 2017, in press, DOI: 10.1007/s10822-017-0025-6.

2017/04/16   Confirmed that the products are compatible to Gaussian16W 64-bit multi-processor version (Revision A.03). I really appreciate great help of Gaussian, Inc.

2017/03/28   All series of HyperChem of Hypercube, Inc. are available from our web site.

2016/12/29   Origin of the receptor subtype selectivity via quantum mechanics has been accepted for publication. Motonori Tsuji, et. al., FEBS Open Bio. 7, 391-396, 2017, DOI: 10.1002/2211-5463.12188.

2016/04/16   Confirmed that the products are compatible to Gaussian09W 64-bit multi-processor version (Revision E.01). I really appreciate great help of Gaussian, Inc.

2015/10/07   Origin of the ligand recognition mechanism in the nuclear receptor superfamily has been published. Motonori Tsuji. J. Mol. Graph. Model. 62, 262-275, 2015.

Helix H3 Three-Point Initial-Binding Hypothesis

2015/09/13   A proposed molecular mechanism of ATRA via retinoid X receptor (using core technologies of Docking Study with HyperChem and Homology Modeling Professional for HyperChem) has been accepted for publication. Motonori Tsuji, et. al. J. Comput. Aided Mol. Des. 29, 975-988, 2015.

2015/04/17   Discovery of the underlying rule for the facial stereoselectivity, which is the most important and unsolved issue in organic chemistry, has recently been accepted for publication. Motonori Tsuji. Asian J. Org. Chem. 4, 659-673, 2015.

Tsuji Model for Facial Stereoselectivity

2014/03/18   A paper regarding the folding mechanism and the agonism and atagonism mechanism of the ligand-binding domain in the nuclear receptor superfamily has recently been published. Motonori Tsuji. J. Struct. Biol. 185, 355-365, 2014.

The folding mechanism and the agonism and atagonism mechanism of the ligand-binding domain in the nuclear receptor superfamily

 

2013/07/01    10th Anniversary

2012/11/30    Acquired patent rights regarding structural-based pharmacophre prediction technology.

2012/07         Homology Modeling Professional for HyperChem was cited in an article.Plant Cell Physiol. 2012 Jul; 53 (9): 1638-1647.

2010/12         Homology Modeling Professional for HyperChem was cited in an article.Biochemistry 2010 Dec; 49 (50): 10647-10655.

2010/04/30    Homology Modeling Professional for HyperChem was cited in an article.Biochemical and Biophysical Research Communications 2010 Apr 30; 339 (2): 173-177.

2008/02         Docking Study with HyperChem and Homology Modeling Professional for HyperChem were cited in an article. Science 2008 Feb 1; 319 (5863): 624-7.

2008/01/11    Motonori Tsuji was invited as a guest speaker at Business Research Institute.

2007/11/15    HyperChem of Hypercube, Inc. is available as bundle with my products.

2007/06/29    Docking Study with HyperChem and Homology Modeling Professional for HyperChem were introduced in an article. Motonori Tsuji. Molecular Science 2007; 1: NP004.

2007/06/16    I really appreciate great cooperation of Neil S. Ostlund, President and Chief Executive Officer of Hypercube, Inc.

2006/06/05    Docking Study with HyperChem is available.

2005/12/01    Homology Modeling professional for HyperChem is available.

2005/11/28    Gaussian Interface for HyperChem and ONIOM Interface for Receptor are available.

2005/08/09    My products have been linked to the Gaussian Official site.

2005/07/11    Homology Modeling for HyperChem is available.

2005/05/01    Institute of Molecular Function Web site is started.

2003/08/06    A paper regarding the electronic structure of carboranes and the most stable conformation of cyclopropane ring has been accepted for publication. J. Org. Chem. 69, 4063-4074, 2004.

2003/08/06    A paper regarding carboranyl carbocation has been accepted for publication. J. Org. Chem. 68, 9589-9597, 2003.

2003/07/01    Institute of Molecular Function has been established by Motonori Tsuji.


 

* HyperChem is a registered trademark of Hypercube, Inc.

*" Gaussian is a registered trademark of Gaussian, Inc.

 

Site Map 

Copyright (C) 2004-2017 Institute of Molecular Function. All Rights Reserved.